Vanda Pharmaceuticals | VNDA - Nakit Ve Eşdeğer





Nakit Ve Eşdeğer Değişiklik Tarih
Acadia Pharmaceuticals USD 851.46M 31.77M 2026-03
Agios Pharmaceuticals USD 99.65M 13.95M 2026-06
Akebia Therapeutics USD 162.64M 22.2M 2026-03
Alnylam Pharmaceuticals USD 1.71B 2.46M 2026-06
Anika Therapeutics USD 38.41M 2.61M 2026-06
Arrowhead Research USD 201.64M 112.94M 2025-12
AstraZeneca USD 7.56B 1.85B 2026-03
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Eli Lilly USD 5.28B 1.99B 2026-03
Enanta Pharmaceuticals USD 37.44M 5.14M 2025-12
Halozyme Therapeutics USD 309.75M 175.93M 2026-03
Heron Therapeutics USD 26.12M 2.53M 2026-03
Insmed USD 582.19M 71.74M 2026-03
J&J USD 20.42B 1.27B 2026-06
Lexicon Pharmaceuticals USD 38.09M 3.76M 2026-03
Ligand Pharmaceuticals USD 115.08M 59.85M 2026-03
Merck USD 5.33B 9.24B 2026-03
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Moderna USD 1.72B 185M 2026-06
Novartis USD 6.88B 2.68B 2026-03
Pfizer USD 1.7B 561M 2026-03
PTC Therapeutics USD 1.05B 215.9M 2026-06
Puma Biotechnology USD 53.52M 1.14M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 6.35B 806M 2026-06
Takeda JPY 460.98B 134.07B 2026-06
Teva Pharmaceutical Industries USD 3.74B 185M 2026-03
Ultragenyx Pharmaceutical USD 175M 246M 2026-03
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12
Veracyte USD 299.52M 36.38M 2026-06